NeuBase Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NeuBase Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2023.
  • NeuBase Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2023 was 65.9 %, a 130% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 65.9 +37.2 +130% Sep 30, 2023
Q2 2023 52.1 +28.3 +119% Jun 30, 2023
Q1 2023 38.9 +19.1 +95.9% Mar 31, 2023
Q4 2022 33.8 +16.3 +92.6% Dec 31, 2022
Q3 2022 28.6 +13.7 +91.6% Sep 30, 2022
Q2 2022 23.8 +11.3 +90.5% Jun 30, 2022
Q1 2022 19.9 +9.41 +89.9% Mar 31, 2022
Q4 2021 17.6 +4.79 +37.5% Dec 31, 2021
Q3 2021 14.9 -2.2 -12.8% Sep 30, 2021
Q2 2021 12.5 -10 -44.6% Jun 30, 2021
Q1 2021 10.5 -42.2 -80.1% Mar 31, 2021
Q4 2020 12.8 -44.7 -77.8% Dec 31, 2020
Q3 2020 17.1 -72.3 -80.8% Sep 30, 2020
Q2 2020 22.5 +104 Jun 30, 2020
Q1 2020 52.7 +31 +143% Mar 31, 2020
Q4 2019 57.5 +47.5 +475% Dec 31, 2019
Q3 2019 89.5 +77.2 +632% Sep 30, 2019
Q2 2019 -81.3 -96.1 -649% Jun 30, 2019
Q1 2019 21.7 +3.15 +17% Mar 31, 2019
Q4 2018 10 -14.3 -58.7% Dec 31, 2018
Q3 2018 12.2 -10.6 -46.5% Sep 30, 2018
Q2 2018 14.8 -6.92 -31.9% Jun 30, 2018
Q1 2018 18.5 -2.53 -12% Mar 31, 2018
Q4 2017 24.3 +9.37 +62.9% Dec 31, 2017
Q3 2017 22.8 +8.38 +58% Sep 30, 2017
Q2 2017 21.7 +9.41 +76.4% Jun 30, 2017
Q1 2017 21 +10.9 +108% Mar 31, 2017
Q4 2016 14.9 +5.64 +61% Dec 31, 2016
Q3 2016 14.5 +3.32 +29.8% Sep 30, 2016
Q2 2016 12.3 -1.03 -7.72% Jun 30, 2016
Q1 2016 10.1 -7.39 -42.2% Mar 31, 2016
Q4 2015 9.25 -15 -61.8% Dec 31, 2015
Q3 2015 11.1 -9.75 -46.7% Sep 30, 2015
Q2 2015 13.3 -6.83 -33.9% Jun 30, 2015
Q1 2015 17.5 +7.78 +80% Mar 31, 2015
Q4 2014 24.2 +17.2 +244% Dec 31, 2014
Q3 2014 20.9 -2.49 -10.6% Sep 30, 2014
Q2 2014 20.2 -14 -40.9% Jun 30, 2014
Q1 2014 9.72 -105 -91.5% Mar 31, 2014
Q4 2013 7.04 -341 -98% Dec 31, 2013
Q3 2013 23.4 +779 Sep 30, 2013
Q2 2013 34.1 +226 Jun 30, 2013
Q1 2013 115 +271 Mar 31, 2013
Q4 2012 348 Dec 31, 2012
Q3 2012 -756 Sep 30, 2012
Q2 2012 -192 Jun 30, 2012
Q1 2012 -157 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.